Aviv Regev

Aviv Regev

Professor of Biology; Core Member, Broad Institute; Investigator, Howard Hughes Medical Institute

Aviv Regev pioneers the use of single-cell genomics and other techniques to dissect the molecular networks that regulate genes, define cells and tissues, and influence health and disease.





Kate Mulherin



Assistant Phone


  • PhD, 2003, Tel Aviv University
  • MS, 1997, Tel Aviv University

Research Summary

We are interested in biological networks, gene regulation and evolution. Our work focuses on dissecting complex molecular networks to determine how they function and evolve in the face of genetic and environmental changes, as well as during differentiation, evolution and disease.


  • National Academy of Sciences, Member, 2019
  • Memorial Sloan Kettering Cancer Center Paul Marks Prize for Cancer Research, 2017
  • International Society for Computational Biology (ISCB) Innovator Award, 2017
  • ISCB Fellow, 2016
  • Earl and Thressa Stadtman Scholar Award, 2014
  • Howard Hughes Medical Institute, HHMI Investigator, 2013
  • NIH Director’s Pioneer Award, 2008
  • Sloan Research Fellowship, 2008
  • Overton Prize, 2008

Recent Publications

  1. Deciphering eukaryotic gene-regulatory logic with 100 million random promoters. de Boer, CG, Vaishnav, ED, Sadeh, R, Abeyta, EL, Friedman, N, Regev, A. 2020. Nat. Biotechnol. 38, 56-65.
    doi: 10.1038/s41587-019-0315-8PMID:31792407
  2. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Haas, BJ, Dobin, A, Li, B, Stransky, N, Pochet, N, Regev, A. 2019. Genome Biol. 20, 213.
    doi: 10.1186/s13059-019-1842-9PMID:31639029
  3. Nuclei multiplexing with barcoded antibodies for single-nucleus genomics. Gaublomme, JT, Li, B, McCabe, C, Knecht, A, Yang, Y, Drokhlyansky, E, Van Wittenberghe, N, Waldman, J, Dionne, D, Nguyen, L et al.. 2019. Nat Commun 10, 2907.
    doi: 10.1038/s41467-019-10756-2PMID:31266958
  4. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Jerby-Arnon, L, Shah, P, Cuoco, MS, Rodman, C, Su, MJ, Melms, JC, Leeson, R, Kanodia, A, Mei, S, Lin, JR et al.. 2018. Cell 175, 984-997.e24.
    doi: 10.1016/j.cell.2018.09.006PMID:30388455
  5. Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Gate, RE, Cheng, CS, Aiden, AP, Siba, A, Tabaka, M, Lituiev, D, Machol, I, Gordon, MG, Subramaniam, M, Shamim, M et al.. 2018. Nat. Genet. 50, 1140-1150.
    doi: 10.1038/s41588-018-0156-2PMID:29988122
  6. BROCKMAN: deciphering variance in epigenomic regulators by k-mer factorization. de Boer, CG, Regev, A. 2018. BMC Bioinformatics 19, 253.
    doi: 10.1186/s12859-018-2255-6PMID:29970004
  7. Efficient Generation of Transcriptomic Profiles by Random Composite Measurements. Cleary, B, Cong, L, Cheung, A, Lander, ES, Regev, A. 2017. Cell 171, 1424-1436.e18.
    doi: 10.1016/j.cell.2017.10.023PMID:29153835
  8. A single-cell survey of the small intestinal epithelium. Haber, AL, Biton, M, Rogel, N, Herbst, RH, Shekhar, K, Smillie, C, Burgin, G, Delorey, TM, Howitt, MR, Katz, Y et al.. 2017. Nature 551, 333-339.
    doi: 10.1038/nature24489PMID:29144463
  9. Massively parallel single-nucleus RNA-seq with DroNc-seq. Habib, N, Avraham-Davidi, I, Basu, A, Burks, T, Shekhar, K, Hofree, M, Choudhury, SR, Aguet, F, Gelfand, E, Ardlie, K et al.. 2017. Nat. Methods 14, 955-958.
    doi: 10.1038/nmeth.4407PMID:28846088
  10. Scaling single-cell genomics from phenomenology to mechanism. Tanay, A, Regev, A. 2017. Nature 541, 331-338.
    doi: 10.1038/nature21350PMID:28102262
More Publications


Photo credit: Casey Atkins